Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Florida Investor is an investment research and media company that provides specialized analysis of the biotechnology and life sciences sectors. The platform focuses on clinical-stage companies, offering in-depth evaluations of drug pipelines, clinical trial designs, and regulatory catalysts such as PDUFA dates. Through its subscription-based Substack and active social media presence, it translates complex scientific and medical data into financial insights for investors. The company is recognized for its focus on small-to-mid-cap biotech stocks and its ability to analyze high-stakes binary events in the drug development lifecycle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Florida Investor.